More information: Flavio T. Vieira et al, Hidden malnutrition in obesity and knee osteoarthritis: Assessment, overlap with sarcopenic obesity and health outcomes, Clinical Nutrition (2025). DOI ...

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association ...

The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.

Malnutrition could be a hidden culprit that lowers quality of life for people with larger bodies, especially if they have a health condition like ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

BMI, Body-mass index. HADS, Hospital Anxiety and Depression Scale. Tables. ... World Congress on Osteoarthritis (OARSI) 2025 Annual Meeting; World Congress on Osteoarthritis ...

In the 68-week study by Novo Nordisk, the maker of semaglutide, 407 people with obesity and knee osteoarthritis were randomly assigned to receive semaglutide in the form of Wegovy or a placebo.

Background Patellofemoral pain (PFP) occurs frequently, and may be related to patellofemoral osteoarthritis (PFOA). Obesity is associated with increased risk of knee OA. This systematic review ...

Body mass index is beginning to emerge as a major risk factor for several chronic diseases, including type 2 diabetes, cardiovascular diseases, and osteoarthritis.

Venn diagram demonstrating the overlap between malnutrition and sarcopenic obesity (SO) of n = 46 individuals with advanced knee osteoarthritis and BMI>35kg/m 2.Credit: Clinical Nutrition (2025 ...